Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02992275 · ClinicalTrials.gov registry record · NA
NMES to Improve Hip Abductor Strength and Balance
A NA study, sponsored by Baltimore VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02992275: Completed NA study, sponsored by Baltimore VA Medical Center.
NCT02992275 is a NA study that has completed, run by Baltimore VA Medical Center. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02992275, a NA study, has completed, sponsored by Baltimore VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will examine the addition of neuromuscular electrical stimulation (NMES) on the hip abductors during strength training and a fall prevention program for improving muscle strength and improving balance. All individuals in this study will receive NMES to their hip abductors and will participate in a fall reduction program.
Primary Outcome
Mobility will be measured with the use of the mini-BesTest
Interventions
- OTHER Neuromuscular electrical stimulation (NMES)
- OTHER Multi-Modality Balance Intervention (MMBI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT02992275 record still lists
NCT02992275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Neuromuscular electrical stimulation (NMES) is the first listed.
NCT02992275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02992275 about?
NCT02992275 is a clinical study titled "NMES to Improve Hip Abductor Strength and Balance". This study will examine the addition of neuromuscular electrical stimulation (NMES) on the hip abductors during strength training and a fall prevention program for improving muscle strength and improving balance. All individuals in this study will receive NMES to their hip abductors and will partici...
What is the current status of trial NCT02992275?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-06-01. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT02992275?
The interventions under investigation include: Neuromuscular electrical stimulation (NMES) (OTHER), Multi-Modality Balance Intervention (MMBI) (OTHER).
Who is sponsoring clinical trial NCT02992275?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02992275's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy